These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29321549)

  • 41. Orange flavonoid hesperetin modulates cardiac hERG potassium channel via binding to amino acid F656.
    Scholz EP; Zitron E; Kiesecker C; Thomas D; Kathöfer S; Kreuzer J; Bauer A; Katus HA; Remppis A; Karle CA; Greten J
    Nutr Metab Cardiovasc Dis; 2007 Nov; 17(9):666-75. PubMed ID: 16926094
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exploring chemical substructures essential for HERG k(+) channel blockade by synthesis and biological evaluation of dofetilide analogues.
    ; Guo D; Klaasse E; de Vries H; Brussee J; Nalos L; Rook MB; Vos MA; van der Heyden MA; Ijzerman AP
    ChemMedChem; 2009 Oct; 4(10):1722-32. PubMed ID: 19725081
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lipid roles in hERG function and interactions with drugs.
    Kudaibergenova M; Perissinotti LL; Noskov SY
    Neurosci Lett; 2019 May; 700():70-77. PubMed ID: 29758301
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lidoflazine is a high affinity blocker of the HERG K(+)channel.
    Ridley JM; Dooley PC; Milnes JT; Witchel HJ; Hancox JC
    J Mol Cell Cardiol; 2004 May; 36(5):701-5. PubMed ID: 15135665
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes.
    Suessbrich H; Schönherr R; Heinemann SH; Attali B; Lang F; Busch AE
    Br J Pharmacol; 1997 Mar; 120(5):968-74. PubMed ID: 9138706
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The synergic modeling for the binding of fluoroquinolone antibiotics to the hERG potassium channel.
    Ryu S; Imai YN; Oiki S
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3848-51. PubMed ID: 23711922
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Block of hERG channel by ziprasidone: biophysical properties and molecular determinants.
    Su Z; Chen J; Martin RL; McDermott JS; Cox BF; Gopalakrishnan M; Gintant GA
    Biochem Pharmacol; 2006 Jan; 71(3):278-86. PubMed ID: 16325148
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blockade of HERG channels by the class III antiarrhythmic azimilide: mode of action.
    Busch AE; Eigenberger B; Jurkiewicz NK; Salata JJ; Pica A; Suessbrich H; Lang F
    Br J Pharmacol; 1998 Jan; 123(1):23-30. PubMed ID: 9484850
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differentiating drug-induced multichannel block on the electrocardiogram: randomized study of dofetilide, quinidine, ranolazine, and verapamil.
    Johannesen L; Vicente J; Mason JW; Sanabria C; Waite-Labott K; Hong M; Guo P; Lin J; Sørensen JS; Galeotti L; Florian J; Ugander M; Stockbridge N; Strauss DG
    Clin Pharmacol Ther; 2014 Nov; 96(5):549-58. PubMed ID: 25054430
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ivabradine prolongs phase 3 of cardiac repolarization and blocks the hERG1 (KCNH2) current over a concentration-range overlapping with that required to block HCN4.
    Lees-Miller JP; Guo J; Wang Y; Perissinotti LL; Noskov SY; Duff HJ
    J Mol Cell Cardiol; 2015 Aug; 85():71-8. PubMed ID: 25986146
    [TBL] [Abstract][Full Text] [Related]  

  • 51. BeKm-1 is a HERG-specific toxin that shares the structure with ChTx but the mechanism of action with ErgTx1.
    Zhang M; Korolkova YV; Liu J; Jiang M; Grishin EV; Tseng GN
    Biophys J; 2003 May; 84(5):3022-36. PubMed ID: 12719233
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular determinants of KCNQ1 channel block by a benzodiazepine.
    Seebohm G; Chen J; Strutz N; Culberson C; Lerche C; Sanguinetti MC
    Mol Pharmacol; 2003 Jul; 64(1):70-7. PubMed ID: 12815162
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Block of the hERG channel by bupivacaine: Electrophysiological and modeling insights towards stereochemical optimization.
    Sintra Grilo L; Carrupt PA; Abriel H; Daina A
    Eur J Med Chem; 2011 Aug; 46(8):3486-98. PubMed ID: 21624711
    [TBL] [Abstract][Full Text] [Related]  

  • 54. I(Kr): the hERG channel.
    Tseng GN
    J Mol Cell Cardiol; 2001 May; 33(5):835-49. PubMed ID: 11343409
    [TBL] [Abstract][Full Text] [Related]  

  • 55. hERG drug response measured in droplet bilayers.
    Portonovo SA; Salazar CS; Schmidt JJ
    Biomed Microdevices; 2013 Apr; 15(2):255-9. PubMed ID: 23160842
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structural modeling of the hERG potassium channel and associated drug interactions.
    Maly J; Emigh AM; DeMarco KR; Furutani K; Sack JT; Clancy CE; Vorobyov I; Yarov-Yarovoy V
    Front Pharmacol; 2022; 13():966463. PubMed ID: 36188564
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extracellular potassium dependency of block of HERG by quinidine and cisapride is primarily determined by the permeant ion and not by inactivation.
    Barrows B; Cheung K; Bialobrzeski T; Foster J; Schulze J; Miller A
    Channels (Austin); 2009; 3(4):239-48. PubMed ID: 19617705
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interactions of the antimalarial drug mefloquine with the human cardiac potassium channels KvLQT1/minK and HERG.
    Kang J; Chen XL; Wang L; Rampe D
    J Pharmacol Exp Ther; 2001 Oct; 299(1):290-6. PubMed ID: 11561091
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Single HERG delayed rectifier K+ channels expressed in Xenopus oocytes.
    Zou A; Curran ME; Keating MT; Sanguinetti MC
    Am J Physiol; 1997 Mar; 272(3 Pt 2):H1309-14. PubMed ID: 9087606
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Compilation and physicochemical classification analysis of a diverse hERG inhibition database.
    Didziapetris R; Lanevskij K
    J Comput Aided Mol Des; 2016 Dec; 30(12):1175-1188. PubMed ID: 27783199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.